---
title: "JINLING PHARM. released its 2024 annual performance, with a net profit attributable to the parent company of 40.4098 million yuan, a decrease of 61.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233667952.md"
description: "JINLING PHARM. released its 2024 annual report, with operating revenue of 3.281 billion yuan, a year-on-year increase of 2.74%. The net profit attributable to the parent company was 40.4098 million yuan, a year-on-year decrease of 61.95%. The net profit after deducting non-recurring gains and losses was 48.9222 million yuan, a year-on-year decrease of 40.44%. The basic earnings per share were 0.0682 yuan, and it is proposed to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-03-28T16:01:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233667952.md)
  - [en](https://longbridge.com/en/news/233667952.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233667952.md)
generator: "portal-rs"
---

# JINLING PHARM. released its 2024 annual performance, with a net profit attributable to the parent company of 40.4098 million yuan, a decrease of 61.95%

According to the Zhitong Finance APP, JINLING PHARM. (000919.SZ) released its 2024 annual report, showing an operating income of 3.281 billion yuan, a year-on-year increase of 2.74%. The net profit attributable to shareholders of the listed company was 40.4098 million yuan, a year-on-year decrease of 61.95%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.9222 million yuan, a year-on-year decrease of 40.44%. The basic earnings per share were 0.0682 yuan. In addition, it plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [000919.CN](https://longbridge.com/en/quote/000919.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Frontieras North America Advances a Low-Sulfur Industrial Carbon That Heavy Industry Is Already Looking For](https://longbridge.com/en/news/296814189.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [MMK: Fit-For-Future programme drove resilient earnings and margin stability despite market softness](https://longbridge.com/en/news/296440411.md)
- [Li-S Energy ships first lithium-sulfur battery cells to US Army DEVCOM for evaluation](https://longbridge.com/en/news/296792089.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**